VLEKT is characterized by a very low total energy intake (650800 kcal per day), carbohydrate restriction to less than 30 g/day, fat intake of around 20 g/day with a preference for sources of unsaturated fats such as extra-virgin olive oil, and protein intake of 0.81.2 g/kg of reference body weight (i.e., calculated based on the patient's height) ( MAD was developed in 2003 as an alternative to the conventional KD, particularly in the context of treating drug-resistant epilepsy ( MCTKD was developed in 1971 by Huttenlocher et al
Healthcare professionals and patients should maintain awareness of potential indicators
Cuando un operador invierte en explicar reglas, probabilidades y gestin de banca, demuestra que prioriza la permanencia saludable del usuario sobre las ganancias a corto plazo
NO TIME
Transform your health journey Doctor-approved medications, customized to your needs
Finished dosage development may involve oral, injectable, or other permitted dosage formats depending on formulation route, market authorization, and applicable regulatory requirements
